Operating Lease, Right-of-Use Asset of Edwards Lifesciences Corp from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Edwards Lifesciences Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Edwards Lifesciences Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $96,500,000, a 7.6% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Edwards Lifesciences Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $96,500,000 -$7,900,000 -7.6% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $99,000,000 +$6,200,000 +6.7% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $96,900,000 -$1,500,000 -1.5% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $98,200,000 +$13,800,000 +16% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $104,400,000 +$13,500,000 +15% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $92,800,000 +$7,900,000 +9.3% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 $98,400,000 +$9,900,000 +11% 31 Mar 2024 10-Q 29 Apr 2024 2024 Q1
Q4 2023 $84,400,000 -$7,900,000 -8.6% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $90,900,000 +$3,200,000 +3.6% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $84,900,000 +$700,000 +0.83% 30 Jun 2023 10-Q 28 Jul 2023 2023 Q2
Q1 2023 $88,500,000 -$1,600,000 -1.8% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 $92,300,000 +$200,000 +0.22% 31 Dec 2022 10-K 12 Feb 2024 2023 FY
Q3 2022 $87,700,000 +$2,900,000 +3.4% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $84,200,000 -$400,000 -0.47% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $90,100,000 +$1,600,000 +1.8% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 $92,100,000 -$2,100,000 -2.2% 31 Dec 2021 10-K 13 Feb 2023 2022 FY
Q3 2021 $84,800,000 -$4,700,000 -5.3% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $84,600,000 -$100,000 -0.12% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $88,500,000 +$13,000,000 +17% 31 Mar 2021 10-Q 28 Apr 2021 2021 Q1
Q4 2020 $94,200,000 +$14,100,000 +18% 31 Dec 2020 10-K 14 Feb 2022 2021 FY
Q3 2020 $89,500,000 +$16,200,000 +22% 30 Sep 2020 10-Q 26 Oct 2020 2020 Q3
Q2 2020 $84,700,000 +$13,500,000 +19% 30 Jun 2020 10-Q 27 Jul 2020 2020 Q2
Q1 2020 $75,500,000 +$5,600,000 +8% 31 Mar 2020 10-Q 28 Apr 2020 2020 Q1
Q4 2019 $80,100,000 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $73,300,000 30 Sep 2019 10-Q 25 Oct 2019 2019 Q3
Q2 2019 $71,200,000 30 Jun 2019 10-Q 26 Jul 2019 2019 Q2
Q1 2019 $69,900,000 31 Mar 2019 10-Q 26 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.